Audit of ablation procedures for AF Barts and The London.

Slides:



Advertisements
Similar presentations
AF ablation with 3D mapping: our technique and results
Advertisements

Atrial Fibrillation Ablation: My personal experience
Ali Alsayegh, MD, FRCPC,FACC Consultant Cardiologist, Consultant Cardiac Electrophysiologist.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Atrial Fibrillation 2014 Christopher L. Fellows, MD, FACC, FHRS
Concomitant Atrial Fibrillation - allways Maze? - Robert JM Klautz chief department Cardiothoracic Surgery.
1/ Incidence of AF: 5% of the population > 60 years, candidates for AF surgery in USA 2/ Etiologies: among patients applying for a life insurance:
Hybrid AF Ablation Sequential thoracoscopic and percutaneous ablation for Lone AF Dr Guy Haywood Consultant Cardiac Electrophysiologist South West Cardiothoracic.
Tecniche alternative dell' ablazione trans catetere della Fibrillazione Atriale Laboratorio di Elettrofisiologia e Cardiostimolazione Cattedra e Divisione.
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.
Optimal Method and Outcomes of Catheter Ablation of Persistent AF: The STAR AF 2 Trial Atul Verma, Jiang Chen-yang, Tim Betts, John Radcliffe, Jian Chen,
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.
AFib Management and the Role of Catheter Ablation.
Ablation for Paroxysmal Atrial Fibrillation (APAF) Trial Presented at The American College of Cardiology Scientific Session 2006 Presented by Dr. Carlo.
INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION St. Mary’s Hospital February – August 2007.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary’s University of London.
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.
Katheterablatie van atriumfibrilleren Waar staan we? Lukas Dekker.
John R Onufer MD FHRS.  Paroxysmal(that which terminates spontaneously) Persistent Sustained > 7 days, or lasting < 7 days but requires pharmacologic.
Amr Kamal, M.D Alexandria Main University Hospital Alexandria- Egypt ECRA 2010.
Dubrava University Hospital Zagreb, Croatia DEPARTMENT OF CARDIAC SURGERY RF Ablation of Atrial Fibrillation in Valvular Heart Surgery Patients.
Late outcomes of the Cox-Maze IV procedure for atrial fibrillation Matthew C. Henn MD, Timothy S. Lancaster MD, Jacob R. Miller MD, Laurie A. Sinn RN,
THE RHYTHM IN LIFE THE SEASONS DO NOT PUSH ONE ANOTHER; NEITHER DO CLOUDS RACE THE WIND ACROSS THE SKY. ALL THINGS HAPPEN IN THEIR OWN GOOD TIME.
Catheter Ablation of Atrial Fibrillation in the Elderly
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies.
Atrial Fibrillation What is New in the 2006 ACC/AHA/ESC Guidelines HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation. May 2007.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial by Atul Verma, Roberto Mantovan,
RADIOFREQUENCY ABLATION OF FIBRILLATION: What clinicians should know. DR CARLOS LABADET Electrophysiology Sector Dr. Cosme Argerich Hospital.
Catheter Ablation of Atrial Fibrillation: Who? How? How Good? John D. Day, M.D. Director, Utah Cardiovascular Research Institute Utah Heart Clinic Arrhythmia.
#1009 Evaluation & Management of Atrial Fibrillation November 16 to 19 Stephen F. Schaal, MD Professor of Internal Medicine Division of Cardiology The.
AF: Catheter Ablation Isolation of the 4 pulmonary veins Linear lesions to create additional lines of block 1.
Barts and The London NHS Trust NHS Barts and The London NHS Trust NHS AF ablations at SBH August 2008 – August 2009 Patients undergoing first ablation.
Redo afib ablation John R Onufer MD FHRS
Asklepios Klink St. Georg, Hamburg
Atrial Fibrillation Ablation: Who and Why ?
SWEDMAF Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Carina Blomstrom-Lundqvist SWEDMAF Trial.
Catheter Ablation of Atrial Fibrillation in the Last 10 Years: Breakthroughs and Advances Dr. Feifan Ouyang Asklepios Klinik St. Georg Hamburg Sept. 19th,
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Rhythm and Rate Control for Atrial Fibrillation Tom Wallace, MD Cardiac Electrophysiology CHI St. Vincent Heart Clinic Arkansas.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Atrial fibrillation April 2010 : 1,980,000 March 2011: 2,550,000 hits November 2014: 9,500,000 hits.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
PULMONARY VEIN STENOSIS
Atrial fibrillation J Heinsimer MD.
Fontan Global Case Conference Richard J. Czosek, MD 6/28/17
Is There a Need to Address AF in patients Undergoing Valve Surgery?
ALFIO STUTO SEAL WHEALTH TEAM, SIRACUSA, ITALY
Successful Cox Maze Procedure During Mitral Valve Surgery Restores Patient Survival Without Increasing Operative Risk Niv Ad, MD Chief, Cardiac Surgery.
Left atrial ablation for atrial fibrillation. A
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Surgical treatment of atrial fibrillation: State of the art, 2012
Volume 11, Issue 1, Pages (January 2014)
AF ablation with 3D mapping: our technique and results
(p for noninferiority = )
MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.
The Outcome of the Cox Maze Procedure in Patients With Previous Percutaneous Catheter Ablation to Treat Atrial Fibrillation  Niv Ad, MD, Linda Henry,
ΝΟΣΟΣ ΤΑΧΥΒΡΑΔΥΚΑΡΔΙΑΣ: ΕΜΦΥΤΕΥΣΗ ΒΗΜΑΤΟΔΟΤΗ Η ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ ; ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΕΠ.Α ΚΑΡΔΙΟΛΟΓΟΣ ΓΝΘ ΙΠΠΟΚΡΑΤΕΙΟ.
Junaid A.B. Zaman et al. JACEP 2017;3:
Patients with Advanced Fibrotic Myopathy Should be Surgically Ablated
Risk Factor Modification
Right Isthmus Ablation Reduces Supraventricular Arrhythmias After Surgery for Chronic Atrial Fibrillation  Francesco Onorati, MD, Antonio Esposito, MD,
K.R. Julian Chun et al. JACEP 2017;3:
Left-Sided Surgical Ablation for Patients With Atrial Fibrillation Who Are Undergoing Concomitant Cardiac Surgical Procedures  Niv Ad, MD, Sari D. Holmes,
Arrhythmia surgery for atrial fibrillation associated with atrial septal defect: Right-sided maze versus biatrial maze  Yu-Mi Im, MS, Joon Bum Kim, MD,
Matthew C. Henn, MD, Christopher P. Lawrance, MD, Laurie A
NICE 2014 Check pulse in patients presenting with:
Presentation transcript:

Audit of ablation procedures for AF Barts and The London

AF burden Framingham – Lifetime risk of developing AF = 25% – Mortality: SMR =1.9 ♀ 1.5 ♂ NHS audit – 1% of budget spent on AF ↓↓Quality of life – Symptoms of AF – Side effects of medication Benjamin, E. J. et al. "Impact of atrial fibrillation on the risk of death: the Framingham Heart Study." Circulation (1998): Stewart, S. et al. "Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK." Heart 90.3 (2004):

Are effective treatments available? Antiarrhythmic drugs – Toxicity: AFFIRM – No benefit over rate control – SR has a prognostic benefit Rate control and anticoagulation – As good as AADs: Prognosis QOL – Ximelagatran

Non pharmacological methods Pacemaker – Pace to suppress triggers of AF – Multisite or biatrial pacing Atrial defibrillators Surgical ablation Catheter ablation

Mechanisms of AF

Ablation strategies Isolation/destruction of triggers: Target pulmonary vein isolation (PVI) Total PVI ± other triggers Modification of atrial substrate: Linear lesions in left atrium, right atrium or both Wide circumferential lesions around pulmonary veins Catheter maze Left atrial maze and PVI

Pulmonary vein isolation

Linear ablation in the left atrium

Catheter maze

Standards from published data ProcedureCentre/DateN Permanent AF % Complication rate % Repeat Procedures % Maintenance of SR % LA linear ablation Kuck Hamburg (if lines complete) WACA Pappone Milan PAF 68 Permanent 4 PVI Haisaguerre Bordeaux (66 off drugs)

Worldwide survey of AF ablation Cappato et al. ESC 2004 Data from 777 centres Number of cases – 18 in 1995, 5050 in 2002 – Median of 37.5 cases per centre (range 1-600) Commonest procedure – Right atrial maze – Target PVI – Electrical disconnection of all PVs Outcomes – 8745 pts in 90 centres – 27.3% >1 procedure – 76% asymptomatic (24% on antiarrhythmic drugs) – 6% major complication rate

St Bartholomew’s data PATS database (EP and EP2) Research database – Catheter maze study – Coarse AF study Patient letters – DMS/EPR viewer Telephone patients

Total number of procedures 100 procedures in 73 patients

Increasing number of procedures

Patients N=73 50±8 years 58M 15F Cardiac diagnosis: Type of AF:

Outcomes: improvement in symptoms?

Outcomes: maintenance of sinus rhythm?

Need for antiarrhythmic drugs?

Need for repeat procedures? Number of procedures per patient:

Success of 1 st procedure

Procedure times 281±120 49±25

Complications Major n=4 (4.5%) – 2 Tamponade – 1 Stroke – 1 Severe PV stenosis Up to June 03 (11.4%) Since July 03 (0%) Minor n=7 (8.0%) – 2 transient ST elevation – 2 mild PV stenosis – 1 tip of active fix pacing wire in RA – 2 haematoma

Catheter maze study Baseline characteristics: – 23 patients (19M 4F) – 49 ± 9 years – AF duration 4 ± 3 years (11 ± 9 months continuously) – 2.7 ± 1.7 DCCV – 3.3 ± 1 antiarrhythmic drugs – LA diameter 4.9 ± 0.9 cm Mean follow up 10±7 months

Catheter maze outcome * Index Catheter Maze N=23 AF or AFL recurrence Medium term Sinus rhythm N=17 (77%) Permanent AF accepted N=3 Repeat ablation * In AF awaiting further treatment N=2 1 death from unrelated cause 2 nd or 3 rd AF or AFL recurrence 2 4 1

Results: symptoms and QOL Baseline SR -6 ± 7+14 ± months change vs 6 weeks -34 ± 24*-6 ± 37 6 weeks change vs baseline - 58 ± 29 Modified Karolinska (0-140) *P < 0.05 AF or AFL

Surgical Maze – BRACUS stidy Bipolar Radiofrequency Ablation for Chronic atrial fibrillation in patients Undergoing mitral valve Surgery PatientDiagnosisOperationDateRhythm at follow up 65 ♀ MR due to RhVD MVR + TV annulplastyJune 04Atrial flutter 71 ♀ MR due to MVP MV and TV repair and annulplasty June 04SR 68♂ MR due to MVP MVRAug 04(AF)

Conclusions Clinical need for improved pharmacological or non pharmacological treatments for AF AF ablation at St Bartholomew’s is effective and at a level with published data Low but important complication rate

St Bartholomew’s as a lead national centre for AF ablation Increasing number of cases Prospective symptom, QOL and rhythm collection Publishing and presenting our data Research Catheter Maze Coarse AF BRACUS Training Centre of excellence for industry Ensite NavX 4.0 and 5.0 Digital Image fusion